Aarkstore - Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Aarkstore - Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014

Description:

“Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014”report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. – PowerPoint PPT presentation

Number of Views:167

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014


1
Congestive Heart Failure (Heart Failure) -
Pipeline Review, H2 2014
Category Pharmaceuticals Healthcare
  • Browse Complete Report -
  • http//www.aarkstore.com/pharmaceuticals-healthcar
    e/63081/congestive-heart-failure-heart-failure-pip
    eline-review

2
Congestive Heart Failure (Heart Failure) -
Pipeline Review, H2 2014
3
Summary
  • Global Markets Directs, Congestive Heart
    Failure (Heart Failure) - Pipeline Review, H2
    2014, provides an overview of the Congestive
    Heart Failure (Heart Failure)s therapeutic
    pipeline.This report provides comprehensive
    information on the therapeutic development for
    Congestive Heart Failure (Heart Failure),
    complete with comparative analysis at various
    stages, therapeutics assessment by drug target,
    mechanism of action (MoA), route of
    administration (RoA) and molecule type, along
    with latest updates, and featured news and press
    releases. It also reviews key players involved in
    the therapeutic development for Congestive Heart
    Failure (Heart Failure) and special features on
    late-stage and discontinued projects.
  • Global Markets Directs report features
    investigational drugs from across globe covering
    over 20 therapy areas and nearly 3,000
    indications. The report is built using data and
    information sourced from Global Markets Directs
    proprietary databases, Company/University
    websites, SEC filings, investor presentations and
    featured press releases from company/university
    sites and industry-specific third party sources,
    put together by Global Markets Directs team.

4
Summary
  • Drug profiles/records featured in the report
    undergoes periodic updation following a stringent
    set of processes that ensures that all the
    profiles are updated with the latest set of
    information. Additionally, processes including
    live news deals tracking, browser based
    alert-box and clinical trials registries tracking
    ensure that the most recent developments are
    captured on a real time basis.The report
    enhances decision making capabilities and help to
    create effective counter strategies to gain
    competitive advantage. It strengthens RD
    pipelines by identifying new targets and MOAs to
    produce first-in-class and best-in-class
    products.Note Certain sections in the report
    may be removed or altered based on the
    availability and relevance of data for the
    indicated disease.

5
Scope
  • - The report provides a snapshot of the global
    therapeutic landscape of Congestive Heart Failure
    (Heart Failure)- The report reviews key pipeline
    products under drug profile section which
    includes, product description, MoA and RD brief,
    licensing and collaboration details other
    developmental activities - The report reviews
    key players involved in the therapeutics
    development for Congestive Heart Failure (Heart
    Failure) and enlists all their major and minor
    projects- The report summarizes all the dormant
    and discontinued pipeline projects - A review of
    the Congestive Heart Failure (Heart Failure)
    products under development by companies and
    universities/research institutes based on
    information derived from company and
    industry-specific sources- Pipeline products
    coverage based on various stages of development
    ranging from pre-registration till discovery and
    undisclosed stages- A detailed assessment of
    monotherapy and combination therapy pipeline
    projects- Coverage of the Congestive Heart
    Failure (Heart Failure) pipeline on the basis of
    target, MoA, route of administration and molecule
    type- Latest news and deals relating related to
    pipeline products

6
Reasons to buy
  • - Provides strategically significant competitor
    information, analysis, and insights to formulate
    effective RD development strategies- Identify
    emerging players with potentially strong product
    portfolio and create effective counter-strategies
    to gain competitive advantage- Develop strategic
    initiatives by understanding the focus areas of
    leading companies- Identify and understand
    important and diverse types of therapeutics under
    development for Congestive Heart Failure (Heart
    Failure)- Plan mergers and acquisitions
    effectively by identifying key players of the
    most promising pipeline- Devise corrective
    measures for pipeline projects by understanding
    Congestive Heart Failure (Heart Failure) pipeline
    depth and focus of Indication therapeutics-
    Develop and design in-licensing and out-licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and scope- Modify the
    therapeutic portfolio by identifying discontinued
    projects and understanding the factors that drove
    them from pipeline  

7
Table of Content
List of Tables 5List of Figures 7Introduction
8Global Markets Direct Report Coverage
8Congestive Heart Failure (Heart Failure)
Overview 9Therapeutics Development 10Pipeline
Products for Congestive Heart Failure (Heart
Failure) - Overview 10Pipeline Products for
Congestive Heart Failure (Heart Failure) -
Comparative Analysis 11Congestive Heart Failure
(Heart Failure) - Therapeutics under Development
by Companies 12Congestive Heart Failure (Heart
Failure) - Therapeutics under Investigation by
Universities/Institutes 17Congestive Heart
Failure (Heart Failure) - Pipeline Products
Glance 19Late Stage Products 19Clinical Stage
Products 20Early Stage Products 21
8
Table of Content
Congestive Heart Failure (Heart Failure) -
Products under Development by Companies
22Congestive Heart Failure (Heart Failure) -
Products under Investigation by
Universities/Institutes 26Congestive Heart
Failure (Heart Failure) - Companies Involved in
Therapeutics Development 28Acorda Therapeutics,
Inc. 28ARCA biopharma, Inc. 29Asklepios
BioPharmaceutical, Inc. 30Athersys, Inc.
31Bayer AG 32BEAT BioTherapeutics Corp.
33Bioheart, Inc. 34BioLineRx, Ltd.
35Bristol-Myers Squibb Company 36Cardio3
BioSciences SA 37Cardioxyl Pharmaceuticals, Inc.
38Celladon Corporation 39Cellmid Limited 40
9
List Of Tables
  • Number of Products under Development for
    Congestive Heart Failure (Heart Failure), H2 2014
    16Number of Products under Development for
    Congestive Heart Failure (Heart Failure) -
    Comparative Analysis, H2 2014 17Number of
    Products under Development by Companies, H2 2014
    19Number of Products under Development by
    Companies, H2 2014 (Contd..1) 20Number of
    Products under Development by Companies, H2 2014
    (Contd..2) 21Number of Products under
    Development by Companies, H2 2014 (Contd..3)
    22Number of Products under Investigation by
    Universities/Institutes, H2 2014 24Comparative
    Analysis by Late Stage Development, H2 2014
    25Comparative Analysis by Clinical Stage
    Development, H2 2014 26Comparative Analysis by
    Early Stage Development, H2 2014 27Products
    under Development by Companies, H2 2014 28

10
List Of Tables
  • Products under Development by Companies, H2 2014
    (Contd..3) 31Products under Investigation by
    Universities/Institutes, H2 2014 32Products
    under Investigation by Universities/Institutes,
    H2 2014 (Contd..1) 33Congestive Heart Failure
    (Heart Failure) - Pipeline by Acorda
    Therapeutics, Inc., H2 2014 34Congestive Heart
    Failure (Heart Failure) - Pipeline by ARCA
    biopharma, Inc., H2 2014 35Congestive Heart
    Failure (Heart Failure) - Pipeline by Asklepios
    BioPharmaceutical, Inc., H2 2014 36Congestive
    Heart Failure (Heart Failure) - Pipeline by
    Athersys, Inc., H2 2014 37Congestive Heart
    Failure (Heart Failure) - Pipeline by Bayer AG,
    H2 2014 38Congestive Heart Failure (Heart
    Failure) - Pipeline by BEAT BioTherapeutics
    Corp., H2 2014 39Congestive Heart Failure (Heart
    Failure) - Pipeline by Bioheart, Inc., H2 2014
    40Congestive Heart Failure (Heart Failure) -
    Pipeline by BioLineRx, Ltd., H2 2014 41

11
List of Figures
  • Number of Products under Development for
    Congestive Heart Failure (Heart Failure), H2 2014
    16Number of Products under Development for
    Congestive Heart Failure (Heart Failure) -
    Comparative Analysis, H2 2014 17Number of
    Products under Development by Companies, H2 2014
    18Number of Products under Investigation by
    Universities/Institutes, H2 2014 23Comparative
    Analysis by Late Stage Development, H2 2014
    25Comparative Analysis by Clinical Stage
    Development, H2 2014 26Comparative Analysis by
    Early Stage Products, H2 2014 27Assessment by
    Monotherapy Products, H2 2014 73Number of
    Products by Top 10 Targets, H2 2014 75Number of
    Products by Stage and Top 10 Targets, H2 2014
    75Number of Products by Top 10 Mechanism of
    Actions, H2 2014 78Number of Products by Stage
    and Top 10 Mechanism of Actions, H2 2014
    78Number of Products by Top 10 Routes of
    Administration, H2 2014 80

12
Related Reports
  • Global Neurosurgery Market 2015-2019
  • BrainStorm Cell Therapeutics Inc. (BCLI) -
    Financial and Strategic SWOT Analysis Review
  • Ampio Pharmaceuticals, Inc. (AMPE) - Financial
    and Strategic SWOT Analysis Review
  • MiMedx Group, Inc (MDXG) - Financial and
    Strategic SWOT Analysis Review
  • Threshold Pharmaceuticals, Inc. (THLD) -
    Financial and Strategic SWOT Analysis Review

13
Related Reports
  • MEI Pharma, Inc. (MEIP) - Financial and Strategic
    SWOT Analysis Review
  • Titan Pharmaceuticals, Inc. (TTNP) - Financial
    and Strategic SWOT Analysis Review
  • RedHill Biopharma Ltd. (RDHL) - Financial and
    Strategic SWOT Analysis Review
  • Pharmaceuticals Healthcare Market Research
    Reports

14
  • Congestive Heart Failure (Heart Failure) -
    Pipeline Review, H2 2014
  • Published Oct 2014 238 Pages
  • Congestive Heart Failure (Heart Failure) -
    Pipeline Review, H2 2014 report features
    investigational drugs from across globe covering
    over 20 therapy areas and nearly 3,000
    indications.
    Price

Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence 6000
15
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog
  • http//www.aarkstore.com/blog/
  • Conference
  • http//conference.aarkstore.com/
  • News
  • http//www.aarkstore.com/news
About PowerShow.com